Reminder: Expert Access: Barclays Hosted: The Franchises – JAZZ Xywav IP: The Latest, the Scenarios, and Potential Outcomes with IP Expert

Research evidence excerpt

Reminder: Expert Access: Barclays Hosted: The Franchises – JAZZ Xywav IP: The Latest, the Scenarios, and Potential Outcomes with IP Expert

Meet the Analyst

Etzer Darout, PhD, MBA, is a Managing Director and equity

research analyst covering the U.S. Small and Mid-Cap

Biotechnology sector, with over 10 years of sell-side

research experience. Before joining Barclays in June 2025,

Etzer spent three years at BMO Capital Markets as a

Managing Director and senior equity research analyst

covering the Biotechnology sector. Prior to his career on

Wall Street, he spent seven years at Pfizer, researching and

developing therapies for cardiovascular and metabolic

diseases. He graduated from Rutgers University with a PhD

in Organic Chemistry followed by post-doctoral research

at Scripps Research Institute in Jupiter, FL. Etzer also

holds an MBA from the UNC Kenan-Flagler Business

School.

View Analyst Page

Barclays does not provide legal advice. Any oral or written presentation by an external

lawyer to Barclays’ clients does not create an attorney-client relationship or involve the

rendering of legal advice. The views or opinions expressed by an external speaker do not

necessarily reflect the views of Barclays, and are provided for informational purposes

only. Barclays is not responsible for, and has not independently verified, the information

provided by any external speaker and Barclays makes no representation that such

information is correct, complete, or reliable for any purpose.

U.S. Small & Mid Cap Biotechnology

Etzer Darout, PhD, MBA

+1 212 526 6940

BCI, US

This event is intended for Barclays institutional investor clients only. This event is strictly and solely

for the benefit of the intended recipients. Please do not forward this invitation to any other party